Abacus Life, Inc. (ABL)
(Delayed Data from NSDQ)
$10.33 USD
+0.03 (0.29%)
Updated Aug 27, 2024 03:59 PM ET
After-Market: $10.46 +0.13 (1.26%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Abacus Life, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 66 | 0 | 0 | 0 | NA |
Cost Of Goods | 6 | 12 | 1 | 0 | NA |
Gross Profit | 60 | -12 | -1 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 36 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 24 | -12 | -1 | 0 | 0 |
Non-Operating Income | -4 | 11 | 17 | 0 | NA |
Interest Expense | 10 | 0 | 0 | 0 | NA |
Pretax Income | 11 | -1 | 16 | 0 | NA |
Income Taxes | 1 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | 9 | -1 | 16 | 0 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | 10 | -1 | 16 | 0 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 28 | -11 | -1 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 3 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | 24 | -12 | -1 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.95 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.33 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | 0.16 | -0.02 | 0.37 | -0.05 | NA |
Fiscal Year end for Abacus Life, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 29.08 | 21.49 | 33.90 | 21.12 | 11.38 |
Cost Of Goods | 2.74 | 2.72 | 0.83 | 3.36 | 0.97 |
Gross Profit | 26.33 | 18.77 | 33.07 | 17.76 | 10.41 |
SG&A, R&D, and Dept/Amort Expenses | 19.56 | 16.51 | 22.29 | 11.45 | 2.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 6.77 | 2.26 | 10.78 | 6.31 | 8.38 |
Non-Operating Income | 0.17 | 1.32 | -4.20 | -0.86 | 0.12 |
Interest Expense | 4.53 | 3.67 | 6.60 | 2.68 | 0.58 |
Pretax Income | 2.41 | -0.10 | -0.02 | 2.76 | 7.91 |
Income Taxes | 1.76 | 1.17 | -1.43 | 1.71 | 1.18 |
Minority Interest | -0.12 | 0.07 | -0.60 | 0.15 | -0.03 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.65 | -1.28 | 1.40 | 1.05 | 6.72 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.77 | -1.35 | 2.01 | 0.90 | 6.75 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 67.16 | 63.03 | 62.22 | 63.35 | 50.51 |
Diluted EPS Before Non-Recurring Items | 0.18 | 0.11 | -0.10 | 0.01 | 0.13 |
Diluted Net EPS (GAAP) | 0.01 | -0.02 | 0.03 | 0.01 | 0.13 |